LPN LPN
PN ATI Capstone Pharmacology 1 Quiz
1. A nurse is reviewing the medication metformin with a client who has diabetes. Which of the following side effects should the nurse discuss?
- A. Gastrointestinal upset
- B. Increased appetite
- C. Weight loss
- D. Frequent urination
Correct answer: A
Rationale: The correct answer is A: Gastrointestinal upset. Metformin can cause gastrointestinal upset, especially when first starting therapy. It is important to take it with food to reduce these effects. Increased appetite (choice B) and weight loss (choice C) are not common side effects of metformin but may occur due to improved blood sugar control. Frequent urination (choice D) is a symptom of uncontrolled diabetes and not a side effect of metformin.
2. A nurse is caring for a client with a new prescription for clindamycin. Which of the following should the nurse monitor?
- A. Liver function
- B. Serum potassium
- C. Signs of superinfection
- D. Blood glucose
Correct answer: C
Rationale: The correct answer is C: Signs of superinfection. Clindamycin can lead to antibiotic-associated colitis and other superinfections, making it crucial for the nurse to monitor the client for signs of superinfection. Monitoring liver function (choice A) is not typically associated with clindamycin use. Serum potassium levels (choice B) and blood glucose (choice D) are also not directly affected by clindamycin, so they are not the priority for monitoring in this case.
3. A nurse is teaching a client about the use of gabapentin. Which of the following should be included?
- A. It can cause drowsiness
- B. It has no side effects
- C. It is a pain reliever
- D. It can be taken with food
Correct answer: A
Rationale: The correct answer is A: 'It can cause drowsiness.' Gabapentin is known to cause drowsiness, and clients should be warned about this side effect. Choice B is incorrect because gabapentin, like any medication, can have side effects. Choice C is incorrect because although gabapentin is used for pain management, it is not classified as a pain reliever. Choice D is incorrect because gabapentin should be taken as prescribed by the healthcare provider, and specific instructions regarding food intake should be provided based on individual needs.
4. A healthcare provider is assessing a client with congestive heart failure. Which of the following signs should the healthcare provider monitor?
- A. Peripheral edema
- B. Decreased appetite
- C. Fatigue
- D. All of the above
Correct answer: D
Rationale: Correct! In a client with congestive heart failure, peripheral edema, decreased appetite, and fatigue are important signs to monitor as they can indicate worsening heart failure. Peripheral edema is a common sign of fluid retention due to the heart's inability to pump effectively, decreased appetite may indicate worsening heart function, and fatigue can be a result of inadequate cardiac output. Monitoring all these signs is crucial for early intervention and management. Choices A, B, and C are incorrect because monitoring only one symptom may not provide a comprehensive assessment of the client's condition.
5. A healthcare provider is providing education to a client about atorvastatin. Which of the following should be included?
- A. Monitor for muscle pain
- B. Avoid sun exposure
- C. Report any gastrointestinal symptoms
- D. Check liver function tests
Correct answer: A
Rationale: Corrected Rationale: Atorvastatin can cause muscle pain and liver function abnormalities. Monitoring for muscle pain is essential as it can be a sign of a serious side effect called rhabdomyolysis. While liver function tests are necessary before starting atorvastatin, checking them continuously may not be required. Avoiding sun exposure and reporting gastrointestinal symptoms are not directly associated with atorvastatin use.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 50,000 Questions with answers
- All ATI courses Coverage
- 30 days access @ $69.99
ATI LPN Premium
$149.99/ 90 days
- 50,000 Questions with answers
- All ATI courses Coverage
- 30 days access @ $149.99